Sleep Disorders  >>  galantamine hydrobromide  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
galantamine hydrobromide / Generic mfg.
CIRCADIAN, NCT01181921 / 2009-013689-18: The Study: Evaluation of Modulating Effect of Galantamine on Circadian Rhythm in Patients With Mild to Moderate Alzheimer's Disease

Terminated
4
1
Europe
Galantamine
Janssen-Cilag, S.A.
Alzheimer Disease
06/11
06/11

Download Options